Pereira BJG - Search Results

Year	Number of Results
2000	3
2001	2
2002	15
2003	11
2004	17
2005	13
2006	3
2007	5
2008	5
2009	3
2010	1
2012	1
2017	1
2018	1
2019	1
2023	1
2024	1

1

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.

Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. Among authors: pereira bjg. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Clinical Trial.

2

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.

Myette JR, Kano T, Suzuki H, Sloan SE, Szretter KJ, Ramakrishnan B, Adari H, Deotale KD, Engler F, Shriver Z, Wollacott AM, Suzuki Y, Pereira BJG. Myette JR, et al. Among authors: pereira bjg. Kidney Int. 2019 Jul;96(1):104-116. doi: 10.1016/j.kint.2019.01.031. Epub 2019 Mar 16. Kidney Int. 2019. PMID: 31027890 Free article.

3

Biotech leaders call for free press.

Cohen R, Holtzman S, Levin JM, Maraganore JM; Signatories to the Statement. Cohen R, et al. Nat Biotechnol. 2018 Oct 11;36(10):920-922. doi: 10.1038/nbt.4271. Nat Biotechnol. 2018. PMID: 30307914 No abstract available.

4

Chronic kidney disease and the transplant recipient.

Gill JS, Pereira BJ. Gill JS, et al. Blood Purif. 2003;21(1):137-42. doi: 10.1159/000067871. Blood Purif. 2003. PMID: 12596760 Review.

5

Anaemia of chronic kidney disease: an under-recognized and under-treated problem.

Obrador GT, Pereira BJ. Obrador GT, et al. Nephrol Dial Transplant. 2002;17 Suppl 11:44-6. doi: 10.1093/ndt/17.suppl_11.44. Nephrol Dial Transplant. 2002. PMID: 12386258 Review.

6

Polymorphism of immunomodulatory cytokine genes: implications in acute renal failure.

Jaber BL, Liangos O, Pereira BJ, Balakrishnan VS. Jaber BL, et al. Blood Purif. 2004;22(1):101-11. doi: 10.1159/000074930. Blood Purif. 2004. PMID: 14732818 Review.

7

Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease.

Rao M, Pereira BJ. Rao M, et al. Kidney Int. 2005 Oct;68(4):1432-8. doi: 10.1111/j.1523-1755.2005.00554.x. Kidney Int. 2005. PMID: 16164618 Free article. Review. No abstract available.

8

Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure.

Jaber BL, Pereira BJ, Bonventre JV, Balakrishnan VS. Jaber BL, et al. Kidney Int. 2005 Jan;67(1):14-33. doi: 10.1111/j.1523-1755.2005.00051.x. Kidney Int. 2005. PMID: 15610224 Free article. Review.

9

Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients.

Kazmi WH, Obrador GT, Sternberg M, Lindberg J, Schreiber B, Lewis V, Pereira BJ. Kazmi WH, et al. Am J Nephrol. 2005 Mar-Apr;25(2):106-15. doi: 10.1159/000084853. Epub 2005 Mar 10. Am J Nephrol. 2005. PMID: 15802898 Review.

10

A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation.

Sosa MA, Balk EM, Lau J, Liangos O, Balakrishnan VS, Madias NE, Pereira BJ, Jaber BL. Sosa MA, et al. Nephrol Dial Transplant. 2006 Oct;21(10):2825-33. doi: 10.1093/ndt/gfl376. Epub 2006 Jul 22. Nephrol Dial Transplant. 2006. PMID: 16861726 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year